TScan Therapeutics (TCRX) EPS (Basic) (2020 - 2026)
TScan Therapeutics' (TCRX) quarterly EPS (Basic) came in at -$0.22 in Q1 2026, up 22.63% year-on-year from -$0.18 in Q1 2025, and up 11.03% on a QoQ basis from -$0.25 in Q4 2025.
TScan Therapeutics (TCRX) EPS (Basic) (2020 - 2026) Analysis & Trends
TScan Therapeutics (TCRX) has 7 years of EPS (Basic) data on file, last reported at -$0.22 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 22.63% year-over-year to -$0.22 in Q1 2026; TTM through Mar 2026 was -$1.03, a 8.26% increase from a year earlier, with the FY2025 full-year figure at -$1.69, down 31.23% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.22, up from -$0.25 in the prior quarter.
- Over the last five years, EPS (Basic) for TCRX reached as high as -$0.22 in Q1 2026 and fell as low as -$0.93 in Q1 2023.
- Historically, EPS (Basic) has averaged -$0.44 across 5 years, with a median of -$0.32 in 2024.
- Across the five-year window, EPS (Basic) surged 97.35% in 2022 and tumbled 38.21% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.81 in 2022, then soared by 52.64% to -$0.38 in 2023, then slipped by 8.4% to -$0.42 in 2024, then soared by 40.57% to -$0.25 in 2025, then climbed by 11.03% to -$0.22 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.22 in Q1 2026, -$0.25 in Q4 2025, and -$0.28 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 0.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -2.29 |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.25 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -0.29 |
| Dec 31, 2024 | -0.42 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.38 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.51 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -0.81 |
| Sep 30, 2022 | -0.67 |
| Jun 30, 2022 | -0.63 |
| Mar 31, 2022 | -0.67 |
| Dec 31, 2021 | -1.40 |
| Sep 30, 2021 | -1.27 |
| Jun 30, 2021 | -23.71 |